Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Patrizii

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell Death and Differentiation|February 4, 2014
Antitumor effect of miR-197 targeting in p53 wild-type lung cancerM E Fiori, C Barbini, T L Haas, et al.
Cell Death & Disease|August 3, 2013
Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cellsA Chimento, I Casaburi, M Bartucci, et al.
Oncogene|May 23, 2012
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transitionV Coppola, M Musumeci, M Patrizii, et al.
Cell Death and Differentiation|November 26, 2011
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyM Bartucci, S Svensson, P Romania, et al.
Oncogene|May 3, 2011
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancerM Musumeci, V Coppola, A Addario, et al.
Oncogene|June 16, 2015
A microRNA code for prostate cancer metastasisD Bonci, V Coppola, M Patrizii, et al.
Oncogene|February 18, 2014
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cellsM Bartucci, R Dattilo, C Moriconi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell Death and Differentiation|February 4, 2014
Antitumor effect of miR-197 targeting in p53 wild-type lung cancerM E Fiori, C Barbini, T L Haas, et al.
Cell Death & Disease|August 3, 2013
Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cellsA Chimento, I Casaburi, M Bartucci, et al.
Oncogene|May 23, 2012
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transitionV Coppola, M Musumeci, M Patrizii, et al.
Cell Death and Differentiation|November 26, 2011
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyM Bartucci, S Svensson, P Romania, et al.
Oncogene|May 3, 2011
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancerM Musumeci, V Coppola, A Addario, et al.
Oncogene|June 16, 2015
A microRNA code for prostate cancer metastasisD Bonci, V Coppola, M Patrizii, et al.
Oncogene|February 18, 2014
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cellsM Bartucci, R Dattilo, C Moriconi, et al.
Pageof 1